CAI Competitors & Alternatives
Compare Caris Life Sciences, Inc. Common Stock with similar stocks in the same industry
Biotechnology
CAI
Main Stock$24.43
Tradestie Score
56
Market Cap
$8.53B
P/E Ratio
15.4
Revenue Growth
0.3%
Analyst Upside
+39.2%
Top Competitors
221 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$193.06
|
$8.57B | - | 52 | Compare |
|
JAZZ
Jazz Pharmaceuticals, Inc.
|
$245.43
|
$8.30B | 72.1 | 43 | Compare |
|
MRUS
Merus N.V. Common Shares
|
$90.00
|
$7.14B | - | 39 | Compare |
|
CYTK
Cytokinetics Inc.
|
$56.18
|
$6.68B | - | 62 | Compare |
|
RYTM
Rhythm Pharmaceuticals, Inc. Common Stock
|
$113.95
|
$6.64B | - | 39 | Compare |
|
ABVX
Abivax SA American Depositary Shares
|
$90.00
|
$6.38B | - | 62 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$20.41
|
$6.03B | - | 36 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$45.15
|
$6.02B | - | 48 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 44 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$140.97
|
$5.92B | - | 60 | Compare |
More CAI Analysis
Data updated: Nov 11, 2026 | Industry: Biotechnology (SIC 8071)
221 stocks in this industry